pubrio
Lundbeckfonden / Lundbeck Foundation logo

Lundbeckfonden / Lundbeck Foundation

Privately Held
+3
lundbeckfonden.com
Financial Services70 employeesFounded 1954🇩🇰 Denmark

The Lundbeck Foundation is an active industrial Foundation. Hans Lundbeck founded the company H. Lundbeck in 1915. In 1954, his widow, Grete Lundbeck, established the Lundbeck Foundation and transferred her shares in H. Lundbeck to the Foundation as the couple had no heirs. Today H. Lundbeck is a world leader in the development and sales of drugs to treat brain disorders, and the Foundation owns 70% of the company. In 1989 The Lundbeck Foundation acquired its second subsidiary, and today owns 40% of the capital (67% of the votes) in ALK, the world leader in allergy vaccines. In 2011, the Foundation bought 57% of the leading international rescue and assistance company, Falck. In addition to the three subsidiaries, the Foundation owns and manages a portfolio worth approx. DKK 13,9 billion via Lundbeckfonden Invest, as well as a portfolio of biotech investments managed by Lundbeckfonden Ventures. Lundbeckfonden Emerge, is a strategic initiative to accelerate commercialization of early scientific opportunities through investment and active project involvement. The Foundation annually grants DKK 400-500 million to independent scientific research of the highest international quality. Euro 1 million goes to "The Brain Prize" awarded by Grete Lundbeck's European Brain Research Foundation. It is the Foundation's vision to create better lives through new knowledge.

Founded
1954
Employees
70
Industry
Financial Services
Company type
Privately Held
Headquarters
🇩🇰Scherfigsvej 7, Copenhagen, Capital Region 2100, Dk (+2)
Specialties
Financial ServicesBiotechnologyInvestmentHealthcare

Expansion Intelligence

NEW · only on Pubrio

We're tracking Lundbeckfonden / Lundbeck Foundation's market expansion

Global expansion

Live
Stages
ExploringInvestingLandingOperating
Good to know

Frequently Asked Questions Regarding Lundbeckfonden / Lundbeck Foundation

Quick answers about Lundbeckfonden / Lundbeck Foundation's business, markets, and growth signals.

The Lundbeck Foundation is an active industrial Foundation. Hans Lundbeck founded the company H. Lundbeck in 1915. In 1954, his widow, Grete Lundbeck, established the Lundbeck Foundation and transferred her shares in H. Lundbeck to the Foundation as the couple had no heirs. Today H. Lundbeck is a world leader in the development and sales of drugs to treat brain disorders, and the Foundation owns 70% of the company. In 1989 The Lundbeck Foundation acquired its second subsidiary, and today owns 40% of the capital (67% of the votes) in ALK, the world leader in allergy vaccines. In 2011, the Foundation bought 57% of the leading international rescue and assistance company, Falck. In addition to the three subsidiaries, the Foundation owns and manages a portfolio worth approx. DKK 13,9 billion via Lundbeckfonden Invest, as well as a portfolio of biotech investments managed by Lundbeckfonden Ventures. Lundbeckfonden Emerge, is a strategic initiative to accelerate commercialization of early scientific opportunities through investment and active project involvement. The Foundation annually grants DKK 400-500 million to independent scientific research of the highest international quality. Euro 1 million goes to "The Brain Prize" awarded by Grete Lundbeck's European Brain Research Foundation. It is the Foundation's vision to create better lives through new knowledge.

Start your journey today

Start with the platform — or start with a conversation

Use Pubrio on your own, or let our team help you with research, lead generation, or data integration.

Start Journey Image
pubrio

Pubrio glocalizes business, people, and intent data from 50+ local sources into one global graph, giving AI and revenue teams full‑market visibility.​

© 2026 Pubrio. All rights reserved.